AACR 2020 Resources
- Apr 27, 2020–Jul 26, 2020
Because we won’t be able to meet you in person at our booth this year, we’re bringing our booth to you. Explore our virtual booth for new products, instruments, posters, online presentation and resources.
Looking to Connect?
We would love to speak with you, one on one, about your research interests. Please submit your information and a Promega representative will be in contact with you shortly.
Product Information & Resources
Learn more about how Promega is helping advance cancer research, from the laboratory to the clinic, with innovative products and technology platforms.
With many urgent challenges and uncertain outcomes, molecular oncology research requires comprehensive support and resources. We believe in science-driven solutions and personalized service for scientists working with any type of cancer research. Explore our collection of molecular oncology resources, or chat with a scientist to work through your specific needs.
What is Microsatellite Instability (MSI)?
We provide a broad portfolio of functional bioassays and monoclonal antibody characterization tools to accelerate your biologics drug discovery and development. Our custom assay development team can partner with drug developers in the early stages of biologic development to ensure that our bioassays meet your needs.
Cell Viability, Toxicity, & Metabolism
We offer many products to assist your cell biology studies. Our products include assays to monitor cell health and apoptosis, oxidative stress, inflammation and changes in energy metabolism. All our kits are scalable for high-throughput screening and drug discovery applications, and many of our assays have been validated for use in 3D culture.
Protein Dynamics & Cell Signaling
Promega’s unique portfolio of products to study real-time protein dynamics are based on innovative bioluminescent technology. These methods are useful for detecting and studying proteins at endogenous expression levels.
Replace conventional immunoassays, such as Western blots and ELISAs, with new Lumit™ Immunoassays. These assays offer direct luminescence measurement in cell culture, broad dynamic range, and can be completed in as little as 30 minutes.
Lumit™ Immunoassays are available for a range of applications, including protein phosphorylation and pathway analysis, FcRn binding, cytokine detection, metabolite research, and more. You can also build your own Lumit™ immunoassays with our labeling and detection kits.
Our Lumit™ Immunoassay webinar introduces the technolgy and provides examples of applications for cytokine detection, signaling pathway analysis and FcRn binding.
View Webinar On Demand
Technology Platforms to Support Cancer Research
GloMax® Discover Microplate Reader
State-of-the-art luminescence, fluorescence, UV-visible absorbance, BRET and FRET detection
Don’t Miss Our Posters at AACR, June 22–24, 2020!
Quantitative cell-based reporter bioassays for functional characterization of immunotherapeutic biologics targeting co-stimulatory and co-inhibitory immune checkpoint receptors
Presented by: Gopal Krishnan, Sr. Global Product Manager, Biologics
Novel bioluminescent bioassays for the discovery and development of molecular and cellular T cell redirecting cancer therapy
Presented by: Julia Gilden, Sr. Research Scientist, R&D Integrated Biology
Cell-based reporter bioassays for development of Fc-functional and Fc-silent SIRPa/CD47 checkpoint inhibitors
Presented by: Jonathan Mitchell, Sr. Research Scientist, R&D Integrated Biology
Reproducible, MoA-reflecting reporter-based bioassays to enable drug development of biosimilars and biobetters
Presented by: Steve Edenson, Strategic Collaboraions Manager, Life Sciences
Rapid and sensitive determination of cytokine release from cells without the need for sample transfer
Presented by: Dan Lazar, Sr. Research Scientist, R&D Assay Design
Real-time monitoring of PROTAC and molecular glue targeted degradation in living cells
Presented by: Kristin Riching, Sr. Research Scientist, R&D Protein & Nucleic Acid
Targeted degradation of endogenously tagged proteins for phenotypic studies using HaloPROTAC3 and HaloTag technologies
Presented by: Chris Heid, Sr. Global Commercialization Marketing Manager, Pharma/Biotech
A real-time extracellular ATP assay to identify modulators of the innate immune response
Presented by: Drew Niles, Sr. Research Scientist, R&D Assay Design
A homogenous PBMC ADCC bioassay enables bridging studies with ADCC reporter bioassays in immunotherapy monoclonal antibody development
Presented by: Vanessa Ott, Marketing Manager, Biologics
Examination of clinically relevant inhibitor selectivity in live cells across the CDK family
Presented by: Jim Vasta, Sr. Research Scientist, R&D Integrated Biology
A Live Cell Method to Assess E3 Ligase and Target Protein Occupancy for PROTACs
Presented by: Richard Somberg, Director Pharma/Biotech Market Segment
Microsatellite analysis on a novel small footprint capillary electrophoresis instrument
Presented by: Lance Brown, Sr. Global Commercialization Marketing Manager, Clinical Diagnostics
A performance characterization of microsatellite instability and mismatch repair testing methods in endometrial samples
Presented by: Samantha Lewis, Clinical Development Specialist, Clinical Diagnostics